| scholarly article | Q13442814 |
| P50 | author | Jinyi Lang | Q64683552 |
| P2093 | author name string | Lili Chen | |
| Peng Zhang | |||
| Bin Wang | |||
| Dusica Cvetkovic | |||
| C-M Ma | |||
| Xiaoming Chen | |||
| P2860 | cites work | DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation | Q28206029 |
| The effects of G2-phase enrichment and checkpoint abrogation on low-dose hyper-radiosensitivity | Q28569166 | ||
| Comparative effects of indomethacin on cell proliferation and cell cycle progression in tumor cells grown in vitro and in vivo | Q32139429 | ||
| Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18 randomized trials | Q33383729 | ||
| Full-dose reirradiation for unresectable head and neck carcinoma: experience at the Gustave-Roussy Institute in a series of 169 patients | Q33504332 | ||
| Low-dose hypersensitivity: current status and possible mechanisms. | Q34137832 | ||
| Quantitative study of focused ultrasound enhanced doxorubicin delivery to prostate tumor in vivo with MRI guidance | Q34258440 | ||
| Conformal re-irradiation of recurrent and new primary head-and-neck cancer | Q34266157 | ||
| Two molecularly distinct G(2)/M checkpoints are induced by ionizing irradiation | Q34300338 | ||
| Tumor response to ionizing radiation combined with antiangiogenesis or vascular targeting agents: exploring mechanisms of interaction. | Q35149539 | ||
| Treatment of recurrent head and neck cancer: re-irradiation or chemotherapy? | Q36131265 | ||
| The concurrent chemoradiation paradigm--general principles | Q36720868 | ||
| Definitive chemoradiation for the treatment of locally advanced non small-cell lung cancer | Q36935116 | ||
| Low-dose hyper-radiosensitivity: past, present, and future. | Q37122137 | ||
| Concurrent chemotherapy and re-irradiation for locoregionally recurrent head and neck cancer | Q37188049 | ||
| Re-irradiation with concurrent chemotherapy in recurrent head and neck cancer: a decision analysis model based on a systematic review | Q37317047 | ||
| Pulsed low-dose irradiation of orthotopic glioblastoma multiforme (GBM) in a pre-clinical model: effects on vascularization and tumor control. | Q39136744 | ||
| Cell division cycle 25 homolog c effects on low-dose hyper-radiosensitivity and induced radioresistance at elevated dosage in A549 cells | Q39306511 | ||
| Low dose hyper-radiosensitivity and increased radioresistance in mammalian cells | Q41552496 | ||
| Use of cetuximab in combination with pulsed reduced dose-rate radiotherapy in a patient with recurrence of nasopharyngeal carcinoma in the neck | Q42324404 | ||
| Pulsed versus conventional radiation therapy in combination with temozolomide in a murine orthotopic model of glioblastoma multiforme | Q43445755 | ||
| Reirradiation of large-volume recurrent glioma with pulsed reduced-dose-rate radiotherapy | Q44549273 | ||
| Radioresistant tumor cells are present in head and neck carcinomas that recur after radiotherapy | Q45196519 | ||
| Pulsed reduced dose-rate radiotherapy: a novel locoregional retreatment strategy for breast cancer recurrence in the previously irradiated chest wall, axilla, or supraclavicular region | Q46663820 | ||
| Pulsed reduced dose-rate radiotherapy: case report : a novel re-treatment strategy in the management of recurrent glioblastoma multiforme | Q48298213 | ||
| Pulsed reduced dose-rate radiotherapy as re-irradiation for brain metastasis in a patient with lung squamous-celled carcinoma | Q48472373 | ||
| Investigation of pulsed IMRT and VMAT for re-irradiation treatments: dosimetric and delivery feasibilities | Q48547914 | ||
| Low-dose hyperradiosensitivity of human glioblastoma cell lines in vitro does not translate into improved outcome of ultrafractionated radiotherapy in vivo | Q48666697 | ||
| Intensity-modulated radiation therapy for pancreatic and prostate cancer using pulsed low-dose rate delivery techniques. | Q51062089 | ||
| MicroPET/CT imaging of an orthotopic model of human glioblastoma multiforme and evaluation of pulsed low-dose irradiation. | Q53429306 | ||
| Optimization strategies for pulsed low-dose-rate IMRT of recurrent lung and head and neck cancers. | Q55193767 | ||
| Ultrafractionation in A7 human malignant glioma in nude mice. | Q55472584 | ||
| Concomitant chemoradiotherapy versus acceleration of radiotherapy with or without concomitant chemotherapy in locally advanced head and neck carcinoma (GORTEC 99-02): an open-label phase 3 randomised trial | Q58863267 | ||
| The untreated patient with squamous carcinoma of the head and neck | Q71703303 | ||
| Role of HGF/c-met system in invasion and metastasis of oral squamous cell carcinoma cells in vitro and its clinical significance | Q74287365 | ||
| Phase I trial of tirapazamine, cisplatin, and concurrent accelerated boost reirradiation in patients with recurrent head and neck cancer | Q79757577 | ||
| Investigation of pulsed low dose rate radiotherapy using dynamic arc delivery techniques | Q84506321 | ||
| Point/counterpoint: pulsed reduced dose rate radiation therapy is likely to become the treatment modality of choice for recurrent cancers | Q85052493 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1559325815588507 | |
| P577 | publication date | 2015-04-01 | |
| P1433 | published in | Dose-Response | Q20181483 |
| P1476 | title | Local Tumor Control and Normal Tissue Toxicity of Pulsed Low-Dose Rate Radiotherapy for Recurrent Lung Cancer: An In Vivo Animal Study | |
| P478 | volume | 13 |
| Q64068173 | Bridging the translational gap: Implementation of multimodal small animal imaging strategies for tumor burden assessment in a co-clinical trial |
| Q55251068 | Radiomic analysis using contrast-enhanced CT: predict treatment response to pulsed low dose rate radiotherapy in gastric carcinoma with abdominal cavity metastasis. |
| Q38796054 | Tissue TGF-β expression following conventional radiotherapy and pulsed low-dose-rate radiation. |
| Q55635131 | Understanding the pluses of pulses. |
| Q50097946 | Use of Pulsed Low-Dose Rate Radiotherapy in Refractory Malignancies |
Search more.